FDA Import Refusal 799-7758074-5/11/1 — Sanofi Canada

Sanofi Canada — FEI 3002873757

The FDA refused shipment 799-7758074-5/11/1 from Sanofi Canada (Canada) on Nov 22, 2023. The refused product falls under Drugs and Biologics — INSULIN LISPRO PROTAMINE (ANTI-DIABETIC). Cited charges: 2060,75 This firm has 5 or more other import refusals on record.